ijms-logo

Journal Browser

Journal Browser

Neurogenetics: Applications of Precision Medicine and Gene Therapy for Rare Neurogenetic Disorders

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 20 July 2025 | Viewed by 1157

Special Issue Editor


E-Mail Website
Guest Editor
Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54655 Thessaloniki, Greece
Interests: neuroscience; multiple sclerosis; experimental autoimmune encephalomyelitis; intrathecal transplantation; stem cell differentiation; immunohistopathology; in situ hybridization; electron microscopy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Rare neurogenetic disorders represent a profound challenge in neurology and are characterized by complexity, heterogeneity, and low prevalence. These diseases, stemming from diverse hereditary mechanisms—including autosomal dominant, autosomal recessive, X-linked, and mitochondrial inheritance—often manifest with severe, life-threatening, or chronically debilitating symptoms. Despite affecting only a small proportion of the population, they collectively impose a significant burden, with many conditions presenting at birth or during childhood.

Advances in precision medicine and gene therapy offer promising avenues for addressing these disorders. By leveraging the power of molecular genetics, researchers are uncovering pathways toward targeted, personalized interventions. This Special Issue focuses on the intersection of precision medicine, neurogenetics, and gene therapy, with an emphasis on their transformative potential in diagnosing, managing, and treating rare inherited disorders of the nervous system.

Topics of interest include innovations in gene-editing technologies, the use of biomarkers for tailored interventions, and the development of therapies targeting specific rare disorders such as mitochondrial diseases, hereditary neuropathies, motor neuron diseases, and inherited dementias. We invite submissions that explore the molecular underpinnings of these conditions and highlight breakthroughs in personalized treatments designed to improve patient outcomes.

Dr. Paschalis Theotokis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • precision medicine
  • gene therapy
  • neurogenetics
  • rare monogenic diseases
  • inherited nervous system disorders
  • mitochondrial diseases (e.g., LHON, MELAS)
  • lysosomal storage disorders (e.g., Tay–Sachs, Gaucher)
  • hereditary neuropathies (e.g., CMT, hATTR)
  • motor neuron diseases (e.g., SMA, ALS)
  • spinocerebellar ataxias (e.g., SCA)
  • biomarkers in neurology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

30 pages, 764 KiB  
Review
Genetic Basis of Motor Neuron Diseases: Insights, Clinical Management, and Future Directions
by Apostolos Antonakoudis, Stella Aikaterini Kyriakoudi, Despoina Chatzi, Iasonas Dermitzakis, Sofia Gargani, Soultana Meditskou, Maria Eleni Manthou and Paschalis Theotokis
Int. J. Mol. Sci. 2025, 26(10), 4904; https://doi.org/10.3390/ijms26104904 - 20 May 2025
Viewed by 665
Abstract
Motor neuron diseases (MNDs) are a heterogeneous group of neurodegenerative disorders characterized by the progressive loss of motor neurons, resulting in debilitating physical decline. Advances in genetics have revolutionized the understanding of MNDs, elucidating critical genes such as SOD1, TARDBP, FUS [...] Read more.
Motor neuron diseases (MNDs) are a heterogeneous group of neurodegenerative disorders characterized by the progressive loss of motor neurons, resulting in debilitating physical decline. Advances in genetics have revolutionized the understanding of MNDs, elucidating critical genes such as SOD1, TARDBP, FUS, and C9orf72, which are implicated in their pathogenesis. Despite these breakthroughs, significant gaps persist in understanding the interplay between genetic and environmental factors, the role of rare variants, and epigenetic contributions. This review synthesizes current knowledge on the genetic landscape of MNDs, highlights challenges in linking genotype to phenotype, and discusses the promise of precision medicine approaches. Emphasis is placed on emerging strategies, such as gene therapy and targeted molecular interventions, offering hope for personalized treatments. Addressing these challenges is imperative to harness the full potential of genomics for improving outcomes in MNDs. Full article
Show Figures

Figure 1

Back to TopTop